Table 3.
Top 20 most cited articles on the microbiome in irritable bowel syndrome research in the last two decades (2000-2019)
|
SCR
|
Ref.
|
Title
|
Year
|
Source title
|
Cited by
|
| 1st | Roberfroid et al[49] | "Prebiotic effects: Metabolic and health benefits" | 2010 | British Journal of Nutrition | 1147 |
| 2nd | O'Mahony et al[44] | "Lactobacillus and Bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles" | 2005 | Gastroenterology | 1042 |
| 3rd | Claesson et al[37] | "Composition, variability, and temporal stability of the intestinal microbiota of the elderly" | 2011 | Proceedings of the National Academy of Sciences of the United States of America | 836 |
| 4th | Collins et al[38] | "The interplay between the intestinal microbiota and the brain” | 2012 | Nature Reviews Microbiology | 735 |
| 5th | Kassinen et al[40] | "The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects” | 2007 | Gastroenterology | 684 |
| 6th | Pimentel et al[46] | "Rifaximin therapy for patients with irritable bowel syndrome without constipation" | 2011 | New England Journal of Medicine | 659 |
| 7th | Rinttilä et al[48] | "Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR" | 2004 | Journal of Applied Microbiology | 658 |
| 8th | O'Mahony et al[45] | "Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses " | 2009 | Biological Psychiatry | 634 |
| 9th | Rolfe[50] | “The role of probiotic cultures in the control of gastrointestinal health” | 2000 | Journal of Nutrition | 584 |
| 10h | Carabotti et al[36] | “The gut-brain axis: Interactions between enteric microbiota, central and enteric nervous systems" | 2015 | Annals of Gastroenterology | 580 |
| 11th | De Vrese and Schrezenmeir[39] | "Probiotics, prebiotics, and synbiotics" | 2008 | Advances in Biochemical Engineering/Biotechnology | 575 |
| 12th | Rajilić-Stojanović et al[47] | "Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome" | 2011 | Gastroenterology | 545 |
| 13th | Whorwell et al[55] | "Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome" | 2006 | American Journal of Gastroenterology | 541 |
| 13th | Swidsinski et al[54] | "Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease" | 2005 | Journal of Clinical Microbiology | 541 |
| 15th | Malinen et al[41] | "Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR" | 2005 | American Journal of Gastroenterology | 523 |
| 16th | Mayer et al[42] | "Gut/brain axis and the microbiota" | 2015 | Journal of Clinical Investigation | 519 |
| 17th | Simrén et al[52] | "Intestinal microbiota in functional bowel disorders: A Rome foundation report" | 2013 | Gut | 510 |
| 18th | Spiller and Garsed[53] | "Postinfectious irritable bowel syndrome " | 2009 | Gastroenterology | 508 |
| 19th | Rousseaux et al[51] | "Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors" | 2007 | Nature Medicine | 500 |
| 20th | Nobaek et al[43] | "Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome" | 2000 | American Journal of Gastroenterology | 498 |